Back
Genmab A/S 10K Form
Buy
60
GNMSF
Genmab A/S
Last Price:
$313.60
Seasonality Move:
-5%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive GNMSF News And Ratings
See the #1 stock for the next 7 days that we like better than GNMSF
GNMSF Financial Statistics
Sales & Book Value
| Annual Sales: | $3.1B |
|---|---|
| Cash Flow: | $560.7M |
| Price / Cash Flow: | 16.45 |
| Annual Sales: | $93.41 |
| Price / Book: | 3.42 |
Profitability
| EPS (TTM): | 23.50240 |
|---|---|
| Net Income (TTM): | $1.5B |
| Gross Margin: | $2.9B |
| Return on Equity: | 28.26% |
| Return on Assets: | 22.89% |
Genmab A/S Earnings Forecast
Key Genmab A/S Financial Ratios
-
The Gross Profit Margin over the past 18 years for GNMSF is 93.51%.
-
The Selling, General & Administrative Expenses for GNMSF have been equal to 17.61% of Gross Profit Margin.
-
The Research & Development expenses have been 44.01% of Revenue.
-
The Interest Expense is 1.53% of Operating Income.
-
The Net Earning history of GNMSF is 36.44% of Total Revenues.
-
Per Share Earnings over the last 23 years have been positive in 16 years.
Genmab A/S Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | OTCM |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | GNMSF |
| Website: | genmab.com |
Debt
| Debt-to-Equity Ratio: | 0.02 |
|---|---|
| Current Ratio: | 6.03 |
| Quick Ratio: | 6.01 |
Price-to-Earnings
| Trailing P/E Ratio: | 18.13 |
|---|---|
| Forward P/E Ratio: | 0 |
GNMSF Technical Analysis vs Fundamental Analysis
Buy
60
Genmab A/S (GNMSF)
is a Buy
Is Genmab A/S a Buy or a Sell?
-
Genmab A/S stock is rated a BuyThe current Genmab A/S [GNMSF] share price is $319.15. The Score for GNMSF is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.